Page last updated: 2024-08-17

carbostyril and Adenocarcinoma of Lung

carbostyril has been researched along with Adenocarcinoma of Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, BC; Jang, KW; Kang, CW; Kang, HN; Kim, DJ; Kim, H; Kim, HR; Kim, JH; Kim, SM; Lim, SM; Moon, YW; Paik, S; Pyo, KH; Sohn, J; Yun, MR1

Other Studies

1 other study(ies) available for carbostyril and Adenocarcinoma of Lung

ArticleYear
Antitumor Activity and Acquired Resistance Mechanism of Dovitinib (TKI258) in RET-Rearranged Lung Adenocarcinoma.
    Molecular cancer therapeutics, 2015, Volume: 14, Issue:10

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Apoptosis; Benzimidazoles; Catalytic Domain; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Resistance, Neoplasm; Enzyme Activation; HEK293 Cells; Humans; Inhibitory Concentration 50; Lung Neoplasms; Mice, Nude; Models, Molecular; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-ret; Quinolones; src-Family Kinases; Tumor Burden; Xenograft Model Antitumor Assays

2015